Treatment of bladder cancer with cytostatic agents
Steineck, G.; Wijkström, H.; Borghede, G.
Lakartidningen 91(5): 397-404
1994
ISSN/ISBN: 0023-7205 PMID: 8114569 Document Number: 433269
Document emailed within 1 workday
Related Documents
Larsson, P.A. 1999: Treatment with cytostatic agents should be considered in colorectal cancer. it improves prognosis and quality of life Lakartidningen 96(19): 2314-2316Lumholtz, I.B. 1977: Drug information: agents in the treatment of neoplastic diseases. Therapeutic main group: cytostatic agents. 1 Sygeplejersken 77(16): 13
Röttinger, E.M. 1995: Survival of children with primitive neuroectodermal tumors and malignant ependymomas of the central nervous system after treatment with 8 cytostatic agents in one day. A report of the Children's Cancer Group Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 171(5): 303-304
Karrer, K. 1970: Prevention of breast cancer recurrence--cytostatic agents Wiener Klinische Wochenschrift 82(25): 465-467
Halvorsen, S. 1971: Cytostatic agents in treatment of the nephrotic syndrome Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 91(10): 737
Rauh, J.; Pluntke, S.; Müller, C. 2004: Treatment of perivascular extravasation of cytostatic agents MMW Fortschritte der Medizin 146(31-32): 23-24; 26-27
Wisløff, F.; Brinch, L.; Bruserud, O.; Dahl, I.M.; Lamvik, J. 1994: Treatment with high-dose cytostatic agents Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 114(26): 3115-3116
Chlund, K. 1970: Treatment of ulcerative colitis with cytostatic agents Wiener Medizinische Wochenschrift 120(16): 274
Garin, A.M.; Dmitrieva, N.V.; Vyshinskaia, G.V.; Lichintser, M.R. 1987: Rational combinations of hormonal and cytostatic agents in disseminated forms of breast cancer Voprosy Onkologii 33(11): 13-17
Rodriguez, A.; Schatz, A.; Rodriguez, M.; Cornejo, J.; Mendoza, F.; Santamaria, J.; Roa, E.; Rossi, R. 1971: Survival of 17 patients with inoperable bronchial cancer treated with cytostatic agents and radiation in effective minimal doses Revista Medica de Chile 99(8): 560-565
Ringborg, U. 1990: Identification of resistance factors is a step towards optimized treatment with cytostatic agents Lakartidningen 87(21): 1880-1882
Nilsson, A.; Björk, O. 2001: A mannose-binding blood protein reduces the risk of infections drug treatment with cytostatic agents Lakartidningen 98(50): 5780
Iwaguchi, T.; Kitagawa, H. 1978: Effect of chemotherapeutic agents on the growth of rat bladder cancer, BC-47 Gan 69(1): 123-126
Ericson, K.J.; Murthy, P.B.; Bryk, D.J.; Ramkumar, R.R.; Broughman, J.R.; Khanna, A.; Mian, O.Y.; Campbell, S.C. 2019: Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer Clinical Advances in Hematology and Oncology: H&o 17(12): 697-707
Shea, C.R.; Chen, N.; Wimberly, J.; Hasan, T. 1989: Rhodamine dyes as potential agents for photochemotherapy of cancer in human bladder carcinoma cells Cancer Research 49(14): 3961-3965
Svennevig, J.L.; Wennberg, J.E.; Bernstein, O.; Lange, J. 1975: Cytostatic drug combinations in the treatment of metastatic cancer of the breast Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 95(32): 1854-1855; 1866
Tsukagoshi, S. 2003: ImmuCyst intravesical (freeze-dried preparation made from the connaught strain of Bacillus Calmette Guérin) for the treatment of superficial bladder cancer and carcinoma in situ of urinary bladder Gan to Kagaku Ryoho. Cancer and ChemoTherapy 30(7): 1027-1038
Schmidt, C.G. 1971: Alkylating cytostatic agents Der Internist 12(Suppl 1): 119-127
Brieghel, A.; Bille, I.; Sørensen, C. 1991: Cytostatic agents. Pharmacists on the ward Sygeplejersken 91(37): 18-19; 26
Lunglmayr, G. 1971: Cytostatic topical therapy and prevention of recurrence in bladder papillomatosis Wiener Klinische Wochenschrift 83(27): 526-528